Department of Urology, University of Health Sciences, School of Medicine, Ankara Bilkent City Hospital, Ankara-Türkiye.
Department of Urology, Uskudar University School of Medicine, İstanbul-Türkiye.
Ulus Travma Acil Cerrahi Derg. 2023 Sep;29(9):1032-1038. doi: 10.14744/tjtes.2023.99663.
In this study, we aimed to determine the most appropriate antimicrobial agents for prophylactic antibiotic use during emergency and elective transurethral procedures.
The study was conducted in five hospitals located in five different geographical regions of Türkiye. The microorganism cultured in urine before emergency and elective transurethral procedures in these centers between March 2021 and March 2022 were reviewed retrospectively from the hospital records. Demographic data (age and gender) of the patients, comorbid disorders, previous urological procedures, anomalies of the urogenital tract, use of urethral catheters (permanent or clean intermittent catheterization), cultured microorganisms, and antibiotic susceptibilities were noted. The patients hospitalized or had antibiotics for any reason in the previous 1 month were excluded from the study.
A total of 1450 patients, 742 men (51.2%) and 708 women (48.8%), were included in the study. The mean age of the patients was 55.3±19.36 (1-98) years. Diabetes mellitus was evident in 271 (18.7%) patients. The five most common microorgan-isms cultured in urine, in order of frequency, were: ESBL (-) Escherichia coli in 418 (28.8%), ESBL (+) E. coli in 309 (21.3%), Klebsiella pneumonia in 183 (12.6%), Enterococcus faecalis in 124 (8.6%), and Pseudomonas aeruginosa in 89 (6.1%). The susceptibility rates to antimicrobial agents recommended for prophylaxis by the American Urology Association and the European Association of Urology guidelines were found as follows: cefepime 87.1%, ampicillin+sulbactam 84%, TMP-SMX 71.6%, amoxicillin+clavulanate 63.5%, cefoxitin 59%, ceftazidime 58.6%, cefuroxime 43.5%, ceftriaxone 43%, and cefixime 38.4%.
We found that currently recommended antimicrobials provide poor coverage for the most common pathogens isolated. Urologists should consider patient-based antibiotic prophylaxis in endoscopic urethral procedures, follow appropriate proto-cols, and consider local antibiotic resistance.
本研究旨在确定在急诊和择期经尿道手术中预防性使用抗生素的最佳抗菌药物。
该研究在土耳其五个不同地理位置的五家医院进行。回顾性分析了 2021 年 3 月至 2022 年 3 月期间这些中心在急诊和择期经尿道手术前培养的尿液中的微生物。记录患者的人口统计学数据(年龄和性别)、合并症、先前的泌尿科手术、尿路异常、尿道置管(永久性或间歇性清洁导尿)、培养的微生物和抗生素药敏情况。将在过去 1 个月内因任何原因住院或使用抗生素的患者排除在研究之外。
本研究共纳入 1450 例患者,其中男 742 例(51.2%),女 708 例(48.8%)。患者的平均年龄为 55.3±19.36 岁(1-98 岁)。271 例(18.7%)患者患有糖尿病。尿液中培养出的五种最常见的微生物依次为:ESBL(-)大肠埃希菌 418 例(28.8%)、ESBL(+)大肠埃希菌 309 例(21.3%)、肺炎克雷伯菌 183 例(12.6%)、粪肠球菌 124 例(8.6%)和铜绿假单胞菌 89 例(6.1%)。根据美国泌尿外科学会和欧洲泌尿外科学会指南推荐的用于预防的抗菌药物的药敏率如下:头孢吡肟 87.1%、氨苄西林/舒巴坦 84%、TMP-SMX 71.6%、阿莫西林/克拉维酸 63.5%、头孢西丁 59%、头孢他啶 58.6%、头孢呋辛 43.5%、头孢曲松 43%和头孢克肟 38.4%。
我们发现目前推荐的抗菌药物对分离出的最常见病原体的覆盖范围不佳。泌尿科医生应根据患者情况考虑在经尿道内镜检查中进行预防性抗生素治疗,遵循适当的方案,并考虑当地的抗生素耐药性。